Persistent Corneal Epithelial Defect Following Pars Plana Vitrectomy: A Narrative Review.

IF 2.3 4区 医学 Q2 OPHTHALMOLOGY Seminars in Ophthalmology Pub Date : 2025-11-01 Epub Date: 2025-02-24 DOI:10.1080/08820538.2025.2470253
Makan Ziafati, Reza Mirshahi, Maria Vittoria Cicinelli, Rezvaneh Nazari
{"title":"Persistent Corneal Epithelial Defect Following Pars Plana Vitrectomy: A Narrative Review.","authors":"Makan Ziafati, Reza Mirshahi, Maria Vittoria Cicinelli, Rezvaneh Nazari","doi":"10.1080/08820538.2025.2470253","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Persistent corneal epithelial defects (PCEDs) following pars plana vitrectomy (PPV) represent a significant clinical challenge, potentially leading to corneal scarring, vision loss, and other severe complications. This review aims to summarize the prevalence, associated risk factors, and management strategies for PCEDs in the context of PPV, providing evidence-based guidance for clinicians.</p><p><strong>Methods: </strong>A comprehensive systematic review was conducted using PubMed and Embase databases, identifying English-language studies addressing PCEDs after PPV.</p><p><strong>Results: </strong>The prevalence of PCEDs post-PPV varied widely, from 0% to 78.37%, influenced by intrinsic factors such as diabetes mellitus, which impairs corneal nerve function and healing, and extrinsic factors like intraoperative tamponade with C3F8. Management strategies ranged from conservative options like bandage contact lenses to advanced treatments like topical insulin.</p><p><strong>Conclusion: </strong>PCEDs after PPV are multifactorial and demand individualized management. Advanced therapies, particularly serum-based treatments, and topical insulin, show promising outcomes. Further prospective research is warranted to refine these treatments.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"743-755"},"PeriodicalIF":2.3000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08820538.2025.2470253","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Persistent corneal epithelial defects (PCEDs) following pars plana vitrectomy (PPV) represent a significant clinical challenge, potentially leading to corneal scarring, vision loss, and other severe complications. This review aims to summarize the prevalence, associated risk factors, and management strategies for PCEDs in the context of PPV, providing evidence-based guidance for clinicians.

Methods: A comprehensive systematic review was conducted using PubMed and Embase databases, identifying English-language studies addressing PCEDs after PPV.

Results: The prevalence of PCEDs post-PPV varied widely, from 0% to 78.37%, influenced by intrinsic factors such as diabetes mellitus, which impairs corneal nerve function and healing, and extrinsic factors like intraoperative tamponade with C3F8. Management strategies ranged from conservative options like bandage contact lenses to advanced treatments like topical insulin.

Conclusion: PCEDs after PPV are multifactorial and demand individualized management. Advanced therapies, particularly serum-based treatments, and topical insulin, show promising outcomes. Further prospective research is warranted to refine these treatments.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
玻璃体部分切除术后持续性角膜上皮缺损:叙述回顾。
目的:玻璃体部分切除术(PPV)后的持续性角膜上皮缺损(PCEDs)是一个重大的临床挑战,可能导致角膜瘢痕、视力丧失和其他严重并发症。本综述旨在总结PPV背景下pced的患病率、相关危险因素和管理策略,为临床医生提供循证指导。方法:使用PubMed和Embase数据库进行全面的系统评价,确定针对PPV后pced的英语研究。结果:ppv术后PCEDs的患病率差异较大,从0% ~ 78.37%不等,受糖尿病等影响角膜神经功能及愈合的内在因素和术中C3F8填塞等外在因素的影响。治疗策略包括从绷带隐形眼镜等保守选择到局部胰岛素等高级治疗。结论:PPV术后pced是多因素的,需要个体化治疗。先进的治疗方法,特别是基于血清的治疗和局部胰岛素,显示出有希望的结果。需要进一步的前瞻性研究来完善这些治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Seminars in Ophthalmology
Seminars in Ophthalmology OPHTHALMOLOGY-
CiteScore
3.20
自引率
0.00%
发文量
80
审稿时长
>12 weeks
期刊介绍: Seminars in Ophthalmology offers current, clinically oriented reviews on the diagnosis and treatment of ophthalmic disorders. Each issue focuses on a single topic, with a primary emphasis on appropriate surgical techniques.
期刊最新文献
Lacrimal History - Part 106: Doyens of Dacryology Series - The Lacrimal Anatomical Concepts of Ernest-Alexandre Lauth (1803-1837) and Samuel Moritz Pappenheim (1811-1882). Lacrimal History - Part 105: Doyens of Dacryology Series - Paul-Joachim Bernard's 1845 Proposal of Lacrimal Gland Extirpation and the Bitter Arguments with Laugier, Richelot, and Rognetta. Lacrimal History - Part 103: Doyens of Dacryology Series - Alexander Mackay Geddes (1794-1824) and His 1816 Dissertation on Lacrimal Fistula. Immune Checkpoint Inhibitors for the Treatment of Periorbital Non-Melanoma Skin Cancers. Large Language Models Use in Dry Eye Disease: Correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1